This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Schmidt, R. E. Articles by Miller, M. S. Search for Related Content PubMed PubMed Citation Articles by Schmidt, R. E. Articles by Miller, M. S.

(American Journal of Pathology. 1999;155:1651-1660.)
© 1999 American Society for Investigative Pathology

Regular Articles

Insulin-like Growth Factor I Reverses Experimental Diabetic Autonomic Neuropathy

Robert E. Schmidt^*, Denise A. Dorsey^*, Lucie N. Beaudet^*, Santiago B. Plurad^*, Curtis A. Parvin and Matthew S. Miller

From the Divisions of Neuropathology^*
and Laboratory Medicine,
Department of Pathology, Washington University School of Medicine, St. Louis, Missouri; and Cephalon, Inc.,
West Chester, Pennsylvania

Recent studies have suggested a role for neurotrophic substances in the pathogenesis and treatment of diabetic neuropathy. In this study, the effect of insulin-like growth factor I (IGF-I) on diabetic sympathetic autonomic neuropathy was examined in an experimental streptozotocin-induced diabetic rat model. Two months of IGF-I treatment of chronically diabetic rats with established neuroaxonal dystrophy (the neuropathological hallmark of the disease) involving the superior mesenteric ganglion and ileal mesenteric nerves resulted in nearly complete normalization of the frequency of neuroaxonal dystrophy in both sites without altering the severity of diabetes. Treatment with low-dose insulin (to control for the transient glucose-lowering effects of IGF-I) failed to affect the frequency of ganglionic or mesenteric nerve neuroaxonal dystrophy or the severity of diabetes. The striking improvement in the severity of diabetic autonomic neuropathy shown with IGF-I treatment in these studies and the fidelity of the rat model to findings in diabetic human sympathetic ganglia provide promise for the development of new clinical therapeutic strategies.

This article has been cited by other articles:

				V. C. Russo, P. D. Gluckman, E. L. Feldman, and G. A. Werther The Insulin-Like Growth Factor System and Its Pleiotropic Functions in Brain Endocr. Rev., December 1, 2005; 26(7): 916 - 943. [Abstract] [Full Text] [PDF]

				K. F. Kusano, K. L. Allendoerfer, W. Munger, R. Pola, M. Bosch-Marce, R. Kirchmair, Y.-s. Yoon, C. Curry, M. Silver, M. Kearney, et al. Sonic Hedgehog Induces Arteriogenesis in Diabetic Vasa Nervorum and Restores Function in Diabetic Neuropathy Arterioscler. Thromb. Vasc. Biol., November 1, 2004; 24(11): 2102 - 2107. [Abstract] [Full Text] [PDF]

				A. P. Mizisin Comparative Neuropathology and Diabetic Autonomic Neuropathy Am. J. Pathol., November 1, 2003; 163(5): 1703 - 1706. [Full Text] [PDF]

				R. E. Schmidt, D. A. Dorsey, L. N. Beaudet, K. E. Frederick, C. A. Parvin, S. B. Plurad, and M. G. Levisetti Non-Obese Diabetic Mice Rapidly Develop Dramatic Sympathetic Neuritic Dystrophy: A New Experimental Model of Diabetic Autonomic Neuropathy Am. J. Pathol., November 1, 2003; 163(5): 2077 - 2091. [Abstract] [Full Text] [PDF]

				R. E. Schmidt, D. A. Dorsey, L. N. Beaudet, and R. G. Peterson Analysis of the Zucker Diabetic Fatty (ZDF) Type 2 Diabetic Rat Model Suggests a Neurotrophic Role for Insulin/IGF-I in Diabetic Autonomic Neuropathy Am. J. Pathol., July 1, 2003; 163(1): 21 - 28. [Abstract] [Full Text] [PDF]

				A. Nishiyama, D. N. Ishii, P. H. Backx, B. E. Pulford, B. R. Birks, and M. M. Tamkun Altered K+ channel gene expression in diabetic rat ventricle: isoform switching between Kv4.2 and Kv1.4 Am J Physiol Heart Circ Physiol, October 1, 2001; 281(4): H1800 - H1807. [Abstract] [Full Text] [PDF]